Muller et al. used an IL-6 monoclonal antibody to treat mice with acute myocardial infarction and found that the areas of myocardial infarction in the mice treated with the IL-6 monoclonal antibody were larger and the left ventricular ejection fractions were lower than those in the control mice [30]. This evidence concerns the gene IL6 and myocardial infarction.